The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Metformin treatment status and abdominal aortic aneurysm disease progression
Open accessAbstract
Objectives In population-based studies performed on multiple continents over the past two decades, diabetes mellitus has been negatively associated with the prevalence and progression of abdominal aortic aneurysm (AAA) disease. We investigated the possibility that metformin, the primary oral hypoglycemic agent in use worldwide, may influence the progression of AAA disease Methods Pre-operative AAA patients with diabetes were identified from an institutional database. After tabulating individual cardiovascular and demographic risk factors and prescription drug regimens, odds ratios for categorical influences on annual AAA enlargement were calculated via nominal logistical regression. Experimental AAA modeling experiments were subsequently performed in normoglycemic mice to validate the database-derived observations, as well as suggest potential mechanisms of metformin-mediated aneurysm suppression. Results Fifty eight patients met criteria for study inclusion. Of 11 distinct classes of medication considered, only metformin usage was negatively associated with AAA enlargement. This association remained significant after controlling for gender, age, cigarette smoking status and obesity. The median enlargement rate in AAA patients not taking oral diabetic medication was 1.5 mm/year; by nominal logistic regression, metformin, hyperlipidemia, and age ≥70 years were associated with below median enlargement, whereas sulfonylurea therapy, initial aortic diameter ≥40 mm and statin usage were associated with above median enlargement. In experimental modeling, metformin dramatically suppressed the formation and progression, with medial elastin and smooth muscle preservation and reduced aortic mural macrophage, CD8 T cell and neovessel density. Conclusions Epidemiologic evidence of AAA suppression in diabetes may be attributable to concurrent therapy with the oral hypoglycemic agent metformin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Takagi, H., Yamamoto, H., Iwata, K., Goto, S., & Umemoto, T. (2012) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2012.06.021 · Cited by 111
Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice
Tajima, K., Nakamura, A., Shirakawa, J., Togashi, Y., Orime, K., Sato, K., Inoue, H., Kaji, M., Sakamoto, E., Ito, Y., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00133.2013 · Cited by 59
Victor, V. M., Rovira-Llopis, S., Bañuls, C., Diaz-Morales, N., Lopez-Domenech, S., Escribano-López, I., Rios-Navarro, C., Alvarez, A., Gomez, M., Rocha, M., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.017 · Cited by 44
Cited by
Wanhainen, A., Verzini, F., Van Herzeele, I., Allaire, E., Bown, M., Cohnert, T., Dick, F., van Herwaarden, J., Karkos, C., Koelemay, M., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.09.020 · Cited by 2,326
Self-citationWanhainen, A., Van Herzeele, I., Bastos Goncalves, F., Bellmunt Montoya, S., Berard, X., Boyle, J. R., D’Oria, M., Prendes, C. F., Karkos, C. D., Kazimierczak, A., et al. (2024) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2023.11.002 · Cited by 1,207
Self-citationAbdominal aortic aneurysm: update on pathogenesis and medical treatments
Golledge, J. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0114-9 · Cited by 788
Pathogenesis and management of abdominal aortic aneurysm
Golledge, J., Thanigaimani, S., Powell, J. T., & Tsao, P. S. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad386 · Cited by 307
Xu, B., Iida, Y., Glover, K. J., Ge, Y., Wang, Y., Xuan, H., Hu, X., Tanaka, H., Wang, W., Fujimura, N., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312497 · Cited by 73
Self-citation
Metadata
- Authors
- Fujimura, N., Xiong, J., Kettler, E. B., Xuan, H., Glover, K. J., Mell, M. W., Xu, B., & Dalman, R. L.
- Venue
- Journal of Vascular Surgery
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 64
- Issue
- 1
- Pages
- 46-54.e8
- ISSN
- 0741-5214 (ISSN-L)
- OpenAlex
- W2338299575
- Cited by
- 163
- References
- 5
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.